Records containing: Systemic Lupus Erythematosus (SLE)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-02An Exploratory Clinical Study on the Safety and Efficacy of YTS109 Cell in Subjects With Relapsing/Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-03-02An Exploratory Clinical Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-02-27An Exploratory Clinical Study of the Safety and Efficacy of YTS109 Cell Injection in Children With Relapsed/Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-02-23Myocardial Dysfunction in Pediatric Lupus
-
CLINICAL_TRIALS study record update · 2026-02-23CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Adolescents and Young Adults With Systemic Lupus Erythematosus (SLE)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-17A Clinical Study on the Safety and Efficacy of in Vivo CAR-T Cell Therapy (TI-0032-III Injection) for the Treatment of Relapsed and Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2026-02-05A Phase Ib/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of YK012 in the Treatment of Moderate to Severe Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2026-02-05WHEEL: Improving Quality of Life in SLE by Stratified Personalized Health Planning
-
CLINICAL_TRIALS study record update · 2026-02-02An Open-label Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)
-
CLINICAL_TRIALS study record update · 2026-01-28An Exploartory Trial of IMPT-514, An Autologous Anti-CD19/20 CAR T Therapy in Participants With Active, Refractory Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy
-
CLINICAL_TRIALS study record update · 2026-01-28A Multicenter, Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity Characteristics and Preliminary Efficacy of Multiple Ascending Doses of HC022 Injection in Subjects With Systemic Lupus Erythematosus and/or Cutaneous Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2026-01-23Web-Based Data Collection Through the Research Accelerated by You (RAY) Lupus Registry
-
CLINICAL_TRIALS study record update · 2026-01-20Atypical Lupus Presentations and Their Prognostic Implications
-
CLINICAL_TRIALS study record update · 2026-01-14A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2026-01-09Phase I, IIa, Single-Arm, Study of BCMA-CD19-IL-15/IL15sushi cCAR T for the Treatment of Refractory Systemic Lupus Erythematosus, With or Without Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2025-12-22Phase I Clinical Trial of CD19-targeting Chimeric Antigen Receptor T Lymphocyte (MC-1-50) for the Treatment of Refractory Adult Systemic Lupus Erythematosus(SLE)
-
CLINICAL_TRIALS study record update · 2025-12-19GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-12-18A Randomized, Double-Blind, Phase 1/2a Study to Evaluate the Safety, Tolerability, PK and PD of DB-2304 for Injection in Healthy Adult Participants and Participants With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-12-15A Multi-Site, Randomized, Placebo-Controlled, Double-Blind, Phase 2 Clinical Trial of EG-501 for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-11-28Clinical Trial of Blinatumomab in Refractory/Active Systemic Lupus Erythematosus in Children
-
CLINICAL_TRIALS study record update · 2025-11-26Association Between the Expression Levels of MicroRNA-101-3p and Autotaxin in Serum of Systemic Lupus Erythematosus Patients
-
CLINICAL_TRIALS study record update · 2025-11-26A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ib/II Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Anti-BDCA2 Antibody SSGJ-626 in Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-11-24A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-11-24Induction Therapy for Lupus Nephritis With no Added Oral Steroids: An Open Label Randomised Multicentre Controlled Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
-
CLINICAL_TRIALS study record update · 2025-11-20Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)